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Abstract  
Objectives  To assess and compare the implementation of antimicrobial stewardship (AMS) 
interventions recommended within the national AMS toolkits, TARGET and Start Smart Then 
Focus, in English primary and secondary healthcare settings in 2014, to determine the 
prevalence of cross-sector engagement to drive AMS interventions and to propose next 
steps to improve implementation of AMS. 
Methods  Electronic surveys were circulated to all 211 Clinical Commissioning Groups 
(CCGs; primary sector) and to 146 (out of the 159) Acute Trusts (secondary sector) in 
England. Response rates were 39% and 68% for the primary and secondary sectors 
respectively. 
Results  The majority of CCGs and Acute Trusts reported reviewing national AMS toolkits 
formally or informally (60% and 86% respectively).  However, only 13% of CCGs and 46% of 
Acute NHS Trusts had developed an action plan for the implementation of these toolkits.  
Only 5% of CCGs had antimicrobial pharmacists in post; however the role of specialist 
antimicrobial pharmacists continued to remain embedded within Acute Trusts with 83% of 
responding Trusts having an antimicrobial pharmacist at a senior grade.   
Conclusions Review of national AMS toolkits in primary and secondary care is high; 
however implementation of the toolkits, through the development of action plans to deliver 
AMS interventions, requires improvement.  For the first time, we report the extent of cross-
sector and multidisciplinary collaboration to deliver AMS interventions in both primary and 
secondary care sectors in England. Results highlight that further qualitative and quantitative 
work is required to explore mutual benefits and promote best practice.  Antimicrobial 
pharmacists remain leaders for implementing AMS interventions across both primary and 
secondary healthcare sectors.  
 
Introduction 
Antimicrobial resistance (AMR) poses a major threat to healthcare globally, having clinical, 
social and economic implications.[1, 2]  The use and inappropriate use of antimicrobials is a 
recognised driver of drug resistant infections.[3]  Patients with infections due to resistant 
organisms may experience delayed recovery or treatment failure, increased hospital stay 
and increased mortality.[4]   
 
Interventions to reduce inappropriate antimicrobial prescribing can reduce antimicrobial 
resistance or healthcare-acquired infections; and interventions to increase effective 
prescribing are important to improve patient safety clinical outcomes.[5]  Antimicrobial 
Stewardship (AMS) programmes in clinical settings utilise evidence-based guidelines, 
educational activities and regular feedback of antibiotic usage data to prescribers to promote 
rational prescribing.[6-8]  In the UK, a cross government five year strategy to tackle 
antimicrobial resistance was published in 2013.[9]  The strategy outlines seven key areas for 
action, one of which is the optimisation of prescribing practice through implementation of 
AMS programmes. 
 
AMS toolkits for England are freely and openly available to assist organisations to fulfil their 
obligations with regards to national guidance and regulations.  These toolkits are Treat 
Antibiotics Responsibly, Guidance, Education, Tools (TARGET) for primary care, and Start 
Smart then Focus (SSTF) for the secondary healthcare setting.[10, 11]   
 
TARGET 
The TARGET toolkit was launched by Public Health England (PHE) and the Royal College of 
General Practitioners in November 2012.  TARGET resources include guidance (local or 
national antibiotic treatment recommendations), educational materials, and tools that GPs 
can share with patients during consultations (including information on expected duration of 
infection, self-care and back-up prescriptions) and suggested antibiotic practice audits. The 
TARGET materials were updated in 2013 following user testing and evaluations. 
 
SSTF 
SSTF was first published in November 2011.[11,12]  Proof of adherence to SSTF AMS 
principles helps organisations to demonstrate compliance with The Health and Social Care 
Act 2008: Code of Practice on the prevention and control of infections (updated in 2015).[13]  
The Code of Practice states that registered providers should demonstrate “Systems to 
manage and monitor the prevention and control of infection” and “Ensure appropriate 
antimicrobial use to optimise patient outcomes and to reduce the risk of adverse events and 
antimicrobial resistance”.[13]  
 
SSTF recommends that as a minimum, providers should develop an action plan and monitor 
adherence to AMS principles regularly in all clinical areas at least annually including 
evidence of clinical indication and treatment duration (or review date) documented on the 
drug chart; review of antibiotics at 48-72 hours after initiation and documentation of the 
antimicrobial prescribing decision) on the drug chart or in the clinical notes.  It also highlights 
the importance of local guidance for treatment of common conditions based on local 
antibiotic resistance epidemiology. 
 
Aim 
This study aimed to assess and compare the implementation of AMS interventions 
recommended by national AMS toolkits in English primary and secondary care settings 
respectively, to determine the prevalence of cross-sector engagement to drive AMS 
interventions, and to propose next steps to improve implementation of AMS.   
 
Methods 
Two web-based cross-sectional studies - one for primary care and the other for secondary 
care (Supplement 1 & Supplement 2) - were developed and deployed using PHE’s Select 
Survey program to assess the implementation of AMS interventions recommended by the 
TARGET and SSTF toolkits. Questions within both surveys were informed by published AMS 
guidance and designed to build on previous surveys. Both surveys were piloted in smaller 
cohorts (10 Clinical Commissioning Groups (CCGs) and 18 NHS Acute Trusts), and revised 
prior to national circulation.  
 
CCGs are independent statutory bodies governed by members of local GP practices with 
support from health professionals and direct input from people representing patients and 
members of the public.  CCGs have a legal duty to support quality improvement in general 
practice.  All 211 CCGs in England were invited by email to complete the primary care 
survey as part of activities for European Antibiotic Awareness Day (EAAD) in November 
2014.   
 
CCGs are also responsible for commissioning secondary (hospital) and community care 
services for their local geographies.  In England NHS secondary health services are 
provided by acute trusts which may consist of one or more hospitals.   The secondary care 
survey was distributed nationally to antimicrobial pharmacists in 92% of Acute Trusts in 
England (146/159) in May 2014; this was due to incomplete contact details for antimicrobial 
pharmacists in all Trusts following altered clinical delivery in England.  
 
Not all questions were answered by all responding CCGs and Acute Trusts.  Where the 
question was not answered by all responders, 82 CCGs or 100 NHS Acute Trusts, the total 
number of responses (n) for these questions is provided. 
 
These surveys were voluntary service evaluations completed by healthcare professionals 
and thus ethics approval was not required.  Survey responses were analysed using STATA 
(version 13) and Microsoft Excel.  Odds ratios were calculated using logistic regression with 
the implementation of an action plan as the outcome variable to determine the impact of 
reviewing AMS toolkits. 
 
Results: 
Of 82 responding CCGs, 24% had 0-25 member General Practices, 40% contained 26-49 
General Practices, 26% contained 50-74 General Practices, 6% contained 75-99 General 
Practices and 2% contained more than 100 General Practices.  Twenty-eight responding 
Acute Trusts were teaching hospitals. The average number of hospital sites per Acute Trust 
was 2 (range 1 – 5); 27% of Acute Trusts had fewer than 500 beds, 51% had 500-999 beds 
and 22% had over 1000 beds.   
 
Implementation of the National AMS Toolkits 
Of the responding CCGs; 60% had formally or informally reviewed TARGET, 13% had an 
action plan to implement AMS interventions recommended by TARGET (Table 1).  CCGs 
that had either formally or informally reviewed TARGET were over eight times more likely to 
have implemented an action plan (OR=8.68, 95% CI=1.06-71.48, p=0.044), and four times 
more likely to have implemented the use of the TARGET patient information leaflet 
(OR=4.38, 95% CI=1.70-11.27, p=0.002) compared to those which had performed no 
review.  Acute Trusts that had undertaken a formal or informal review of SSTF were over 
three times more likely to have implemented an action plan compared to those that had not 
performed any review (OR=3.33, 95% CI= 1.00-11.06, p=0.050).   
 
Antimicrobial Stewardship interventions recommended by national AMS toolkits 
Key AMS interventions recommended in TARGET and SSTF toolkits are the provision of an 
AMS committee, a written dedicated antimicrobial policy, a written education and training 
strategy and the implementation of audits within these AMS toolkits.  We report the 
implementation of each key AMS activity within primary and secondary healthcare below. 
 
Existence of an AMS Committee 
Fifteen CCGs (18%) reported having a specific AMS committee (Table 1); however the AMS 
role in CCGs was reported to be performed by the Drugs and Therapeutics Committee in 17 
CCGs (21%), Infection Prevention and Control in 11 CCGs (13%) or local Acute Trusts in 2 
CCGs (2%). 
   
Of the 94 (94%) Acute Trusts with AMS committees (Table 1); 99% kept minutes, 92% had 
terms of reference and 87% drafted lists of actions as per the recommended governance 
structure reporting to the Infection Prevention and Control (IPC) committee or equivalent. 
 
Membership of Acute Trust AMS committees was diverse, with some specialities being more 
commonly represented than others (Figure 1).  Microbiologists and specialist antimicrobial 
pharmacists were the most common specialists on Acute Trust AMS committees, whereas 
representation from nurses, physicians, surgeons, intensivists, paediatricians, junior doctors, 
anaesthetists and primary care (CCG) representatives was low. 
 
Written dedicated antimicrobial policy 
Details of antimicrobial policies within primary and secondary care are presented in Table 1.  
Ninety-four (94%) and Ninety-three (93%) of responding Acute Trusts reported having an 
antimicrobial formulary and empirical guidance in place respectively.  Antimicrobial policies 
were updated yearly by 28% of Acute Trusts, every two years (45% of Trusts), every three 
years (by 16% of Trusts) or at greater than four yearly periods (2%).  Five percent of Acute 
Trusts reported updating their antimicrobial policies more regularly than once per year, 1% of 
Acute Trusts reported never updating their antimicrobial policy (n=91). 
                                                                                                                                                                                                                                
AMS Audits 
Few CCGs had implemented suggested AMS audits within the TARGET audit plan or 
collated data as part of CCG wide point prevalence surveys (Table 1); however 53 (69%) of 
responding CCGs had used local antibiotic audits within the past two years.  Implementation 
of AMS audits within the TARGET audit plan was associated with the promotion of TARGET 
within practice prescribing visits (p= 0.03) and with formal or informal review of TARGET (p= 
0.03).   
 
Eighty-three percent of Acute Trusts conducted a Trust-wide antimicrobial point prevalence 
survey (PPS) at least annually, 2% of Acute Trusts reported never conducting one (n=90). 
The majority of respondents collated data for at least one of the AMS audits suggested by 
SSTF within Trust audit plan or as part of Trust wide antimicrobial PPS.  The most frequent 
recommended SSTF audits in Trust wide PPS included: adherence to guidelines of dose, 
route and duration (82%), clinical indication and treatment duration documented on drug 
chart (82%) and IV to oral switch at 48 hours (49%).  Other audits such as review of 
prescription/evidence of documenting decision at 48 hours and time to first dose in severe 
sepsis were less commonly implemented (42% and 40% of Acute Trusts respectively). 
 
Education and Training Strategies 
The implementation of education and training initiatives in primary and secondary care 
varied, as shown in Table 1.  
 
 
 
Additional key aspects to implementing AMS  
The role of specialists in leading AMS interventions 
In primary care, prescribing advisors/medicine management pharmacists led the AMS and 
prescribing strategy in 54 (66%) responding CCGs, whereas only four (5%) CCGs had a 
specialist antimicrobial pharmacist undertaking this role. This role was also undertaken by 
quality or nursing clinical leads in (6%) or by GP clinical leads (2%).   
 
The secondary care survey showed that 94 (94%) responding Acute Trusts had at least one 
specialist antimicrobial pharmacist or pharmacy technician in post, confirming the continuing 
importance of this role.15  The number of these posts per Acute Trust ranged from 0-3 with 
an average of 1.4 per Acute Trust.  Pharmacy technicians (band 5 or higher) and band 7 
pharmacists were found in 2 (2%) and 9 (9%) Acute Trusts respectively.  Band 8a 
pharmacists were embedded within 59 (59%) Acute Trusts.    Pharmacists at bands 8b and 
8c were found in 17 (17%) and 2 (2%) of Acute Trusts respectively.  Consultant pharmacists 
were employed in 5 (5%) Acute Trusts. These posts are usually, but not exclusively, band 8c 
and above. 
 
Survey responses demonstrated that specialist antimicrobial pharmacists in secondary care 
had an extensive role which included: writing antimicrobial guidelines and policies in 96 
(96%) Acute Trusts; making anti-infective formulary decisions i.e. choosing which 
antimicrobials should be available on the trust formulary (91%); being available by phone or 
pager for referrals (91%), performing multi-disciplinary antibiotic review rounds (90%), as 
well as attending Trust infection prevention and control committee meetings (89%).  Horizon 
scanning (70%), attending ward rounds on specialities with high antibiotic use (64%) and 
maintaining awareness of local resistance patterns (53%) were aspects of fewer specialist 
antimicrobial pharmacist roles. 
 
Cross-sector antimicrobial stewardship 
Cross-sector antimicrobial stewardship is the collaboration of different healthcare sectors 
and specialties, working together to deliver AMS across the whole healthcare economy.  The 
secondary care survey collated data on collaboration between CCGs and Acute Trust 
colleagues on the development of antimicrobial guidelines and stewardship interventions 
across both sectors.  Thirty-five (35%) Acute Trust respondents had a working relationship 
with primary care colleagues in their area and were able to provide a named contact.  
 
In order to deliver antimicrobial stewardship, 73 (89%) responding CCGs worked 
collaboratively with an Acute Trust clinician such as a microbiologist, 71 (87%) with GP 
practices, 62 (76%) with community service providers and 45 (55%) worked with community 
pharmacies.  As shown in Table 2, the proportion of CCGs and Acute Trusts which 
participated in the production of joint AMS-related materials and training was low. Joint anti-
infective guidelines and policies were the most common resource produced.   
 
Regarding future plans for primary-secondary sector collaboration, 39 (48%) of responding 
CCGs reported that they did not know of any plans to develop cross-sector stewardship 
interventions with Acute Trusts.  Thirty-four (41%) reported that they would collaborate with 
Acute Trusts on cross-sector AMS within the following 1-2 years.  Nine (11%) CCGs stated 
that they had no such future plans. 
 
Discussion 
Results of our surveys demonstrate that formal or informal review of national AMS toolkits 
was a strong predictor of the implementation of the toolkits and development of 
corresponding AMS action plan in primary and secondary healthcare sectors in England.  
Implementation of the national AMS toolkits has led to a number of actions to improve AMS 
activity; however the results demonstrate that implementation has not been universal, with 
some interventions being conducted more commonly than others.   
 
Fewer than 15% of responding CCGs had implemented suggested AMS audits within the 
TARGET audit plan or collated data as part of CCG wide Point Prevalence Surveys (PPS); 
however the majority of CCGs (69%) implemented their own independent antibiotic audits.   
 
While 74% of Acute Trusts collated data on at least one of the recommended audits in 
SSTF, audits related to “starting smart” such as documentation of dose and duration were 
more commonly implemented than those relating to “then focus” aspects of AMS (e.g. 
evidence of 48 hour review).  These findings support those by Llewelyn et al (2015) who 
found that policies in 100/105 Acute Trusts (95%) recommended antimicrobial prescription 
reviews, but only 46/96 respondents (48%) reported monitoring compliance.[14]  Effective 
implementation of ‘focus’ aspects of AMS guidance such as interventions to increase the 
frequency and effectiveness of post prescription reviews, could help to reduce unnecessarily 
broad-spectrum and prolonged antibiotic therapy.   
 
Components of antimicrobial policies in secondary care have remained consistent from 2011 
to 2014. However, two significant changes are important to highlight; fewer Acute Trusts 
reported utilising an automatic stop policy (from 36% to 19%) and the number of Acute 
Trusts with a separate antimicrobial drug chart/section had increased (from 32% to 59%).[15] 
It is likely that separate antimicrobial sections/drug charts for antimicrobials reduced the 
need for automatic stop policies.  Assessment of individual Trust responses revealed that 
those without an automatic stop policy had a separate antimicrobial section/drug chart where 
only 7 days of antibiotic prescription could be dispensed. 
 
A multidisciplinary committee is recommended to provide an active and collaborative 
approach to AMS.  In primary care AMS was more likely to be overseen by a drugs and 
therapeutics committee than a dedicated AMS committee.  Further investigation is required 
to determine whether these alternative committees are as effective in delivering AMS 
interventions and improved antibiotic prescribing outcomes as dedicated committees or 
groups.  
 
Whilst more than 90% of responding Acute Trusts had a dedicated AMS committee as 
recommended by SSTF, this survey showed that representation of specialties varied.  
Participation from general pharmacists, anaesthetists, surgeons, junior doctors, 
paediatricians, nurses, physicians and primary care representation was low (Figure 1).   
 
Key area three within the UK 5 year AMR strategy is “improving professional education, 
training and public engagement to improve clinical practice and promote wider 
understanding of the need for more sustainable use of antibiotics”.  There was high 
availability of clinical guidelines to promote appropriate prescribing in both primary and 
secondary care. The presence of a written antimicrobial education and training strategy was 
low in both primary and secondary healthcare sectors.  Teaching specifically about 
antibiotics was more common for doctors and pharmacists than for nurses starting work in 
Acute Trusts, a trend mirrored globally.[8]  Over a third of antimicrobial prescribing and 
stewardship training conducted in CCGs was decided by individual CCG trainers. This may 
have led to inconsistency, resulting in low levels of education and training initiatives 
implemented by CCGs.  The first national antimicrobial prescribing and stewardship (AMPS) 
competences were published in 2013.[16] The competences are an integral resource to help 
organisations develop training materials to educate professionals regarding AMS.   
 
Given the move towards integrated care, the fact that at least 50% of CCGs had some 
method of interaction with acute Trusts was encouraging.  However, fewer than 55% of 
CCGs worked with community pharmacies to deliver AMS.  Community pharmacists have a 
key role in educating the public on optimal antibiotic use.  A study conducted by community 
pharmacists stated that almost all the patients interviewed would preferentially attend a 
pharmacy for management of their urinary tract infection symptoms due to “convenience, 
difficulties obtaining a GP appointment and reluctance to trouble GP’s with non-emergency 
problems”.[17]  Therefore developing cross-sector AMS with community pharmacies is 
expected to be beneficial.   
 
In primary care, prescribing advisors or medicines management pharmacists were more 
likely to lead AMS interventions; in the few instances where specialist antimicrobial 
pharmacists fulfilled this role more time was dedicated to AMS.  The role of specialist 
antimicrobial pharmacists continues to remain embedded within Acute Trusts with most 
having a specialist pharmacist for antimicrobials or infection management at NHS agenda for 
change band 8a and above in post.15 In addition the antimicrobial pharmacist role spanned a 
broad range of specialist activities.  It is essential that the important role of these specialist 
pharmacists continues to be recognised following the initial central funding provided in 
2003.18, 19 
 
Pharmacists as a whole are the most engaged professional group in conveying the risks of 
AMR to the public as part of England’s activities for European Antibiotic Awareness Day.20 
This is a crucial activity as increasing knowledge and awareness of AMR within the general 
public is likely to decrease inappropriate demand thus enabling the public to play their part in 
AMS. 
 
Limitations 
The survey was not sent to 100% of Acute Trusts because contact details of antimicrobial 
pharmacists were unavailable due to recent changes in healthcare organisational structures.  
The high response rate from both teaching and non-teaching NHS Acute Trusts across all 
English regions allows these findings to be generalizable across the NHS.  In contrast, the 
lower (39%) response rate from CCGs limits the generalisability of the statements in primary 
care. These surveys did not include responses from prescribers, drug administrators 
(predominantly nurses) and non-specialist pharmacists. Further mixed methods investigation 
of practice is required to understand the behaviour of healthcare workers in relation to AMS.  
 
Next Steps 
Since the completion of this study SSTF has been updated in light of newly published 
evidence and user feedback.12  NICE has recently published a guidance on “Antimicrobial 
stewardship: systems and processes for effective antimicrobial medicine use”, which 
highlighted TARGET and SSTF as resources for organisations and health professionals to 
improve the quality of antimicrobial prescribing and reduce the emergence of resistance in 
healthcare settings.  It is important that those who commission and regulate NHS services 
assess AMS interventions in the practices and organisations they review. In addition, PHE 
needs to continue to work with the professional organisations and Health Education England 
(HEE) to disseminate information about these resources to improve their uptake. A level 2 
patient safety alert to raise awareness of AMS toolkits and AMPS competencies among 
clinical leaders was published jointly by NHE England, PHE and HEE in August 2015. 
Potential barriers and feasibility to adopting cross-sector AMS implementation should be 
explored, as the majority of CCGs who responded to our survey were unaware of any plans 
for their CCG and local Acute Trusts to develop cross-sector stewardship. Further qualitative 
and quantitative work is required to best describe the key components and essential 
elements of antimicrobial stewardship committees to lead to effective behaviour change and 
improved prescribing practice in modern healthcare.   
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Table 1:  Implementation of Antimicrobial Stewardship interventions recommended by 
national AMS toolkits by CCGs and NHS Acute Trusts 
 
% Acute Trusts 
(n=159 at time 
of survey) 
% CCGs 
(n=211 at 
time of 
survey) 
Proportion of responses recieved 63 39 
Proporton of NHS Area Teams represented in survey responses 100 92 
Implementation of the National AMS Toolkits 
% Acute Trusts 
who 
responded to 
survey  
(n=100) 
%CCGs 
who 
responded 
to survey 
(n=82) 
Formally or informally reviewed national AMS toolkits  87 60 
Implemented an action plan to deliver national toolkit AMS 
interventions 
46 13 
Implemented use of the TARGET patient information leaflet * 50 
Using the TARGET educational presentation within the CCG * 59 
Promote TARGET during practice prescribing visits, where 
prescribing advisers visit the GP practice  
* 
58 
Promoted the use of TARGET to GPs for use in 
CPD/revalidation 
* 
46 
AMS Committee   
Existance of an AMS committee dedicated to reviewing 
antimicrobial use 
94 18 
Written dedicated antimicrobial policy   
Have guidelines and/or a policy for antibiotic prescribing 93 99 
Use of a restricted antibiotics list for empirical prescribing 83 73 
Use of intravenous to oral switch policy 82 * 
Use of an automatic stop policy 19 * 
Use of a separate antimicrobial drug chart/section 59 * 
AMS Audits   
Implemented AMS audits suggested by audit plans within the 
national AMS toolkits or collated data as part of organisation-
wide point prevalence surveys 
74 15 
An audit of adherence to guidelines (dose, route & duration) is 
implemented within the audit plan or already collated as part of 
82 * 
* question not asked 
 
 
Table 2:  Joint antimicrobial stewardship related materials or training being produced 
by CCG in collaboration with Acute Trusts  
AMS related materials or training produced in collaboration 
with Acute Trusts 
% CCGs (n=82) 
Joint anti-infective guidelines/policies 54 
Joint anti-infective formulary 48 
Joint anti-infective education for doctors 23 
Joint anti-infective education for nurses 21 
Joint anti-infective education for other healthcare professionals 15 
 
 
 
 
 
 
an organisation-wide PPS 
Education and Training   
Has a written Antimicrobial Education and Training Strategy 24 1 
Competency assessments carried out for prescriber 17 * 
Competency assessments are mandatory 20 * 
All doctors on induction receive antibiotic guidelines 61 61 
All doctors on induction receive antibiotic guidelines and a 
lecture/in person training on antimicrobial prescribing 
63 15 
All doctors on induction receive antibiotic guidelines and need to 
do an e-learning module on antimicrobial prescribing 
23 2 
Teaching on induction for all nurses 27 6 
Teaching on induction for all pharmacists 69 6 
Teaching on induction for non-medical prescribers 18 7 
Mandatory e-learning for senior doctors (registrar and higher) 17 4 
Mandatory e-learning for junior doctors 24 4 
Antimicrobial prescribing and stewardship training is left to 
individual trainers to decide 
* 33 
Figure 1: Membership of AMS committees in NHS Acute Trusts, England, 2014 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
General pharmacists
Anaesthetist
Specialist Surgeons
Junior Doctors
Infectious Disease Specialists
Intensivist
CCG representation
Paediatrician
General Surgeons
General Nurse
Specialist Physicians
General Physicians
Chief pharmacist/Senior Pharmacy Management Team
Infection Prevention and control nurses
Specialist antimicrobial pharmacists
Microbiologist
% Acute Trusts (n=100)
